Close Menu

NEW YORK – Personal Genome Diagnostics (PGDx) has partnered with Japan-based Eisai to develop a liquid biopsy biomarker discovery tool. 

As part of the collaboration, the group will create a kitted next-generation sequencing technology that will allow researchers and biopharma companies to conduct biomarker discovery work on patient blood samples collected during clinical trials.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Guardian reports that Cancer Research UK is cutting its research funding by £44 million.

Los Angeles brought and settled a civil enforcement action against the makers of an at-home test for SARS-CoV-2, NPR reports. 

Technology Review examines factors affecting SARS-CoV-2 testing turnaround times.

In PNAS this week: mapping of ancient human migrations in Europe, recurrent gene fusion in breast cancer, and more.

Sponsored by

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.